Event Details

Join us in London this February to connect with those trailblazing the next wave of CAR and TCR based approaches from pre-clinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to make CAR and TCR therapies better, and faster.

Tuesday, February 21, 1:00 PM

• Session: Workshop E - Identifying Opportunities to Improve Clinical Trial Design
• Speakers:
  Andrea Mayer-Mokler, Senior Director, Global Head Clinical Sciences, Immatics
  Bryan Kobel, Chief Executive Officer, TC BioPharm

Wednesday, February 22, 11:30 AM

• Panel Discussion: Leveraging Clinical Results to Drive Investment in Your Product
• Speakers:
  Blake Aftab, Chief Scientific Officer, Adicet Bio
  Cedrik Britten, Chief Medical Officer, Immatics
  Gary Lee, Chief Scientific Officer, Lyell Immunopharma
  Özlem Anak, Vice President, Global Programme Head, Cell & Gene, Novartis

Wednesday, February 22, 2:00 PM

• Session: Streamlined Manufacturing Processes
• Presentation: Ensuring Product Quality During Manufacturing & Continued Process Improvements
• Speaker: Mamta Kalra, Senior Director, CMC, Immatics

We are looking forward to meeting you!

For more information visit the event's homepage.